β-Amyloid (1-40)
β-Amyloid (1-40) 是阿尔茨海默病患者脑斑块中发现的主要蛋白质。
-
货号:
TK0462 -
规格:
- 500ug
- 1mg
- 5mg
-
价格:
¥0.00
β-Amyloid (1-40) 是阿尔茨海默病患者脑斑块中发现的主要蛋白质。
| CAS No. | 131438-79-4 |
| 生物活性 | β-Amyloid (1-40) is a primary protein in plaques found in the brains of patients with Alzheimer's disease. |
| 分子式 | C194H295N53O58S |
| 分子量 | 4329.82 |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存条件 | Powder, -20°C ,3 years |
| 溶解性数据 | DMSO : 100 mg/mL (23.10 mM; Need ultrasonic),H2O : 100 mg/mL (23.10 mM; Need ultrasonic) |
| 体内研究 | Chronic infusion of β-Amyloid (1-40) into rat cerebroventricle leads to deficit in spatial and non-spatial memory formation. Chronic treatment of β-Amyloid (1-40) does not change lever-pressing performance significantly, but performance declined significantly 30 days after termination of the chronic daily regimen. The soluble unaggregated form of β-Amyloid (1-40), injected into the dorsal hippocampus, does not appear to have behavioral effects on performance or short-term working memory in rats, but multiple repeat injections produced performance decrements several weeks later. Repeated injection of β-Amyloid (1-40) through indwelling cannulae shows promise for development of an animal model of Alzheimer's disease. |
| 体外研究 | β-Amyloid (1-40) and (1-42) are major components of senile plaque amyloids, are physiological peptides present in the brain, cerebrospinal fluid (CSF) and plasma. The levels of CSF β-Amyloid (1-40) and (1-42) show a U-shaped natural course in normal aging.Chronic infusion of beta-amyloid (1-40) for 14 days into the rat cerebroventricle decreased the activity of soluble protein kinase C (PKC) in the hippocampus. Subcellular translocation of PKC to membrane fraction in hippocampal slices of rats treated with beta-amyloid (1-40) is completely abolished under acute stimulation with 0.5 microM phorbol-dibutyrate (PDBu).The further aggregation of β-Amyloid (1-40) |
| 纯度及产品资料 | 98% |